1. Academic Validation
  2. Control of beta-catenin phosphorylation/degradation by a dual-kinase mechanism

Control of beta-catenin phosphorylation/degradation by a dual-kinase mechanism

  • Cell. 2002 Mar 22;108(6):837-47. doi: 10.1016/s0092-8674(02)00685-2.
Chunming Liu 1 Yiming Li Mikhail Semenov Chun Han Gyeong Hun Baeg Yi Tan Zhuohua Zhang Xinhua Lin Xi He
Affiliations

Affiliation

  • 1 Division of Neuroscience, Children's Hospital, Department of Neurology, Harvard Medical School, Boston, MA 02115, USA.
Abstract

Wnt regulation of beta-catenin degradation is essential for development and carcinogenesis. beta-catenin degradation is initiated upon amino-terminal serine/threonine phosphorylation, which is believed to be performed by glycogen synthase kinase-3 (GSK-3) in complex with tumor suppressor proteins Axin and adnomatous polyposis coli (APC). Here we describe another Axin-associated kinase, whose phosphorylation of beta-catenin precedes and is required for subsequent GSK-3 phosphorylation of beta-catenin. This "priming" kinase is Casein Kinase Ialpha (CKIalpha). Depletion of CKIalpha inhibits beta-catenin phosphorylation and degradation and causes abnormal embryogenesis associated with excessive Wnt/beta-catenin signaling. Our study uncovers distinct roles and steps of beta-catenin phosphorylation, identifies CKIalpha as a component in Wnt/beta-catenin signaling, and has implications to pathogenesis/therapeutics of human cancers and diabetes.

Figures